 |
|
|
Founded in 2008, AxelaCare has
been on a quick pace to becoming one of the country’s leading home infusion
therapy providers. Therapies provided range from immune globulin (IG)
therapy to antibiotics and nutrition therapy. Investment from Excellere
Partners in 2010 aided AxelaCare’s innovation and tremendous growth - 30-40%
per year.
AxelaCare’s management team and
New York-based Harvest Partners, LP recently completed the acquisition of the
company from Excellere. Harvest’s senior managing director, Ira Kleinman
noting,
“The company’s [AxelaCare]
investment in processes, technology and people has led to an efficient, scaleable
model with opportunity for continued growth as a larger share of the population
seeks access to these vital services.”
No comments:
Post a Comment